Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Left Atrial Appendage Occlusion vs. Oral Anticoagulation Therapy with NOAC
Author(s): Jens Erik Nielsen Kudsk , A John Camm , Vivek Reddy Start date: Jul 07, 2020

Anticoagulation

Electrophysiology & Arrhythmia
Antithrombotic Therapy after Percutaneous Coronary Intervention
Author(s): Darshni Arishta Jhagroe , Jur ten Berg Added: 3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical… View more

Anticoagulation

Intervention
Author(s): Andrew Archbold Added: 3 years ago
Patients who undergo coronary artery stenting require dual antiplatelet therapy (DAPT) in order to reduce their risk of stent thrombosis. Long-term oral anticoagulation (OAC) is indicated for the primary and secondary prevention of thrombotic events in patients with atrial fibrillation (AF), mechanical heart valves, intra-cardiac thrombus, venous thromboembolic disease and some hypercoagulable… View more

Anticoagulation

Prevention & Chronic Conditions
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR
Author(s): Duk-Woo Park Added: 2 years ago
In this short interview, Dr Duk-Woo Park (Asan Medical Center, KR) discusses the findings from the ADAPT-TAVR Randomized Clinical Trial (NCT03284827). The trial investigated Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR. Presented first at ACC.22, ADAPT-TAVR shows that the overall incidence of leaflet thrombosis on CT scans was less… View more

Anticoagulation
EuroPCR 2021: Findings From the POEM Study
Author(s): Giulio G Stefanini Added: 2 years ago
Dr Giulio Stefanini (Humanitas Research Hospital, Milan, IT) discusses the findings from the multicentre POEM trial.The trial assessed the safety of the bioresorbable polymer-coated everolimus-eluting Synergy® stent in CAD patients undergoing PCI, followed by 1-month dual antiplatelet therapy (DAPT) in patients at high bleeding risk (HBR). Questions: 1. What is the POEM Study and what does it… View more

Anticoagulation

Intervention
Percutaneous Left Atrial Appendage Closure - Dr. Jacqueline Saw
Author(s): Jacqueline Saw Start date: May 07, 2015

Electrophysiology & Arrhythmia
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI
Author(s): George D Dangas Added: 2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021. ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI. … View more

Anticoagulation

Electrophysiology & Arrhythmia
Carlos Morillo
Prof Carlos Morillo is a cardiac electrophysiologist, currently serving in the Chief Division of Cardiology at theLibin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada. Prof Morillo has extensively researched Chagas disease since 1990, and was involved in the initial studies related to autonomic control in the different stages of the disease and the use of beta… View more
Left Atrial Appendage Closure Registr
Author(s): Sameer Gafoor Added: 6 years ago
This interview with Sameer Gafoor from Swedish Heart & Vascular Hospital, Seattle, US discusses One-year data from the left atrial appendage closure EWOLUTION WATCHMAN registry. Filmed by Radcliffe Cardiology on-site at EuroPCR 2017. View more

Electrophysiology & Arrhythmia